Oxy free radical system in heart failure and therapeutic role of oral vitamin E

International Journal of Cardiology

Volumn 57, Issue 2, 1996, Pages 119-127

  Ghatak, Ashim ^a   Brar, Mohan Jeet Singh ^b   Agarwal, Ajay ^b   Goel, Neena ^a   Rastogi, Anil Kumar ^a   Vaish, Arvind Kumar ^b   Sircar, Amulya Ranjan ^b   Chandra, Mahesh ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

catalase; glutathione reductase; heart failure; malonyldialdehyde; superoxide anion; superoxide dismutase

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; FREE RADICAL; GLUTATHIONE REDUCTASE; MALONALDEHYDE; OXYGEN RADICAL; PLACEBO; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; CATALASE; DOUBLE-BLIND METHOD; FEMALE; GLUTATHIONE REDUCTASE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; SUPEROXIDES; TREATMENT OUTCOME; VITAMIN E;

EID: 0030573050     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(96)02787-8     Document Type: Article

References (33)

1. [1] McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441.
2. [2] Burton KP. Evidence of direct toxic effects of free radicals on the myocardium. Free Radic Biol Med 1988; 4: 15-24.
3. [3] Halliwell B. Oxygen radicals: a commonsense look at their nature and medical importance. Med Biol 1984; 62: 71-77.
4. [4] Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol 1983; 23: 239-257.
5. [5] Chandra M, Chandra N, Agarwal R, Kumar A, Ghatak A, Pandey VC. The free radical system in ischemic heart disease. Int J Cardiol 1994; 43: 121-125.
6. [6] Harman D. Free radical theory of aging. Mutat Res 1991; 275: 257-266.
7. [7] Marx JL. Oxygen free radicals linked to many diseases. Science 1987; 235: 235-531.
8. [8] Myers ML, Bolli R, Lekich RF, Hartley CJ, Roberts R. Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation 1985; 72: 915-921.
9. [9] Padh H. Vit. C: newer insights into its biochemical functions. Nutr Rev 1991; 49: 65-70.
10. [10] Prasad K. Effect of oxygen free radical on cardiovascular function, at organ and cellular levels. Am Heart J 1989; 117.
11. [11] Rahman I, Nath N. Glutathione and its redox system, Superoxide anion and superoxide dismutase of PMNL in essential hypertension. Int J Med Res 1988; 88: 64-70.
12. [12] Slater TF. Free radical mechanism in tissue injury. Biochem J 1984; 222: 1-15.
13. [13] Southern PA, Powis G. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin Proc 1988; 381-531.
14. [14] Werns SW, Shea MJ, Lucchesi BR. Free radicals and myocardial injury: pharmacological implications. Circulation 1986; 74: 1-5.
15. [15] Chow CK. Vit. E and oxidative stress. Free Radic Biol Med 1991; 11: 215-232.
16. [16] Belch JJ, Bridges AB. Oxygen free radicals and congestive heart failure. Br Heart J 1991; 65: 245-248.
17. [17] Reddy DS, Chopra K, Singh M, Ganguly NK. Anti-free radical and cardioprotective drugs in ischemic myocardial injury. Drugs Today 1995; 31: 335-349.
18. [18] Hoffman RM, Garewal HS. Antioxidants and the prevention of coronary heart disease. Arch Intern Med 1995; 155: 241-246.
19. [19] Hisatome I, Ishiko R, Miyakoda H, Saito M, Kitamura H, Kinugawa T, Kobayashi M, Kotake H, Mashiba H, Sato R. Excess purine degradation caused by an imbalance in the supply of adenosine triphosphate in patients with congestive heart failure. Br Heart J 1990; 64: 359-361.
20. [20] Singhal PK, Beamish RE, Dhalla NS. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 1980; 191: 421-427.
21. [21] Chen L, Zang Y, Bai B, Zhu M, Zhao B, Hou J, Xin W. Electron spin resonance determination and super oxide dismutase activity in polymorhonuclear leukocytes in congestive heart failure. Can J Cardiol 1992; 8: 756-760.
22. [22] Arnold M Katz. Cellular mechanisms in congestive heart failure. Am J Cardiol 1988; 62: 3A-8A.
23. [23] Criteria Committee, New York Heart Association, Inc. Diseases of heart and blood vessels: nomenclature and criteria for diagnosis, 6th Edition, Boston: Little, Brown and Co., 1964; 114.
24. [24] Curnutte JT, Babior BM. Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes. J Clin Invest 1974; 53: 1662-1672.
25. [25] Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
26. [26] Kakkar P, Das B, Vishwanathan PN. Modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984; 21: 130-132.
27. [27] Aebi H. Catalase in vitro. In: Packer L, editor. Methods in Enzymology, Vol. 105, New York: Academic Press, 1984; 121-126.
28. [28] Racker E. Glutathione reductase. In: Colwick SP, Kaplan NO, editors. Methods in Enzymology, Vol II. New York: Academic Press, 1955; 722-729.
29. [29] Lowry OH. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
30. 10. Proc Natl Acad Sci USA 1985; 82: 901-904.
31. 10: a new drug for cardiovascular diseases; J Clin Pharmacol 1990; 30: 596-608.
32. [32] Chandra M, Gupta V, Rathi AK, Vaish AK, Srimal RC, Pandey VC, Ghatak A, Sircar AR, Bhardwaj RS, Singhal SS. Effect of oral vitamin E on oxy free radical status in acute myocardial infarction. Asian Cardiovasc Thorac Ann 1995; 3: 117-122.
33. [33] Gaziano JM. Antioxidant vitamins and coronary artery disease risk. Am J Med 1994; 97: 18S-21S.